Affiliation:
1. Department of Pharmacology, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599
Abstract
ABSTRACT
We showed previously that activated Ras, but not Raf, causes transformation of RIE-1 epithelial cells, demonstrating the importance of Raf-independent pathways in mediating Ras transformation. To assess the mechanism by which Raf-independent effector signaling pathways contribute to Ras-mediated transformation, we recently utilized representational difference analysis to identify genes expressed in a deregulated fashion by activated Ras but not Raf. One gene identified in these analyses encodes for α-tropomyosin. Therefore, we evaluated the mechanism by which Ras causes the downregulation of tropomyosin expression. By using RIE-1 cells that harbor inducible expression of activated H-Ras(12V), we determined that the downregulation of tropomyosin expression correlated with the onset of morphological transformation. We found that the reversal of Ras transformation caused by inhibition of extracellular signal-regulated kinase activation corresponded to a restoration of tropomyosin expression. Inhibition of p38 activity in Raf-expressing RIE-1 cells caused both morphological transformation and loss of tropomyosin expression. Thus, a reduction in tropomyosin expression correlated strictly with morphological transformation of RIE-1 cells. However, forced overexpression of tropomyosin in Ras-transformed cells did not reverse morphological or growth transformation, a finding consistent with the possibility that multiple changes in gene expression contribute to Ras transformation. We also determined that tropomyosin expression was low in two human tumor cell lines, DLD-1 and HT1080, that harbor endogenous mutated alleles of
ras
, but high in transformation-impaired, derivative cell lines in which the mutant
ras
allele has been genetically deleted. Finally, treatment with azadeoxycytidine restored tropomyosin expression in Ras-transformed RIE-1, HT1080, and DLD-1 cells, suggesting a role for DNA methylation in downregulating tropomyosin expression.
Publisher
American Society for Microbiology
Subject
Cell Biology,Molecular Biology
Reference71 articles.
1. Abe, K., I. P. Whitehead, J. P. O'Bryan, and C. J. Der. 1999. Involvement of N-terminal sequences in the negative regulation of Vav signaling and transforming activity. J. Biol. Chem. 274 : 30410-30418.
2. Alaiya, A. A., B. Franzen, K. Fujioka, B. Moberger, K. Schedvins, C. Silfversvard, S. Linder, and G. Auer. 1997. Phenotypic analysis of ovarian carcinoma: polypeptide expression in benign, borderline and malignant tumors. Int. J. Cancer 73 : 678-683.
3. Bigey, P., S. Ramchandani, J. Theberge, F. D. Araujo, and M. Szyf. 2000. Transcriptional regulation of the human DNA Methyltransferase (dnmt1) gene. Gene 242 : 407-418.
4. Bishop, A. L., and A. Hall. 2000. Rho GTPases and their effector proteins. Biochem. J. 348(Pt. 2): 241-255.
5. Braverman, R. H., H. L. Cooper, H. S. Lee, and G. L. Prasad. 1996. Anti-oncogenic effects of tropomyosin: isoform specificity and importance of protein coding sequences. Oncogene 13 : 537-545.
Cited by
59 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献